UCB (UCB)

Index:

BEL 20

  246.04
   
  • Change Today:
     -0.36
  • 52 Week High:  260.20
  • 52 Week Low:  129.35
  • Currency: Euro
  • Shares Issued: 190.00m
  • Volume: 11,952
  • Market Cap:  46,747m
  • Beta: 1.81

Latest ShareCast News

Belgium's UCB to buy US-based Ra Pharmaceuticals for $2.1bn

By Michele Maatouk

Date: Thursday 10 Oct 2019

(Sharecast News) - Belgian drug maker UCB has agreed to buy US-based clinical-stage biopharmaceuticals company Ra Pharmaceuticals for $2.1bn.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

UCB Market Data

Currency Euro
Share Price   246.04
Change Today   -0.36
% Change -0.15 %
52 Week High  260.20
52 Week Low  129.35
Volume 11,952
Shares Issued 190.00m
Market Cap  46,747m
Beta 1.81

What The Brokers Say

Strong Buy 7
Buy 11
Neutral 3
Sell 0
Strong Sell 0
Total 21
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 24-Oct-2025

Time Volume / Share Price
12:02 8 @  245.90
12:00 13 @  246.00
12:00 91 @  246.00
11:58 1 @  245.80
11:58 13 @  245.90

Top of Page